Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Identification of Risk Factors to Predict the Occurrences of Relapses in Individuals With Schizophrenia Spectrum Disorder in Iran Publisher Pubmed



Davarinejad O1, 2 ; Majd TM2 ; Golmohammadi F2 ; Mohammadi P2 ; Radmehr F2 ; Alikhani M1, 2 ; Motaei T2 ; Moradinazar M2 ; Bruhl A3 ; Bahmani DS3, 4, 5 ; Brand S1, 3, 4, 6, 7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Substance Abuse Prevention Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, 6719851115, Iran
  2. 2. Clinical Research Development Center, Imam Khomeini and Mohammad Kermanshahi and Farabi Hospitals, Kermanshah University of Medical Sciences, Kermanshah, 6719851451, Iran
  3. 3. Center for Affective, Stress and Sleep Disorders (ZASS), University of Basel, Basel, 4002, Switzerland
  4. 4. Sleep Disorders Research Center, Kermanshah University of Medical Sciences, Kermanshah, 6719851115, Iran
  5. 5. Departments of Physical Therapy, University of Alabama at Birmingham, Birmingham, 35209, AL, United States
  6. 6. Department of Sport, Exercise, and Health, University of Basel, Basel, 4002, Switzerland
  7. 7. School of Medicine, Tehran University of Medical Sciences, Tehran, 1416753955, Iran

Source: International Journal of Environmental Research and Public Health Published:2021


Abstract

Schizophrenia Spectrum Disorder (SSD) is a chronic psychiatric disorder with a modest treatment outcome. In addition, relapses are commonplace. Here, we sought to identify factors that predict relapse latency and frequency. To this end, we retrospectively analyzed data for individuals with SSD. Medical records of 401 individuals with SSD were analyzed (mean age: 25.51 years; 63.6% males) covering a five-year period. Univariate and multivariate Penalized Likelihood Models with Shared Log-Normal Frailty were used to determine the correlation between discharge time and relapse and to identify risk factors. A total of 683 relapses were observed in males, and 422 relapses in females. The Relapse Hazard Ratio (RHR) decreased with age (RHR = 0.99, CI: (0.98–0.998)) and with participants’ adherence to pharmacological treatment (HR = 0.71, CI: 0.58–0.86). In contrast, RHR increased with a history of suicide attempts (HR = 1.32, CI: 1.09–1.60), and a gradual compared to a sudden onset of disease (HR = 1.45, CI: 1.02–2.05). Gender was not predictive. Data indicate that preventive and therapeutic interventions may be particularly important for individuals who are younger at disease onset, have a history of suicide attempts, have experienced a gradual onset of disease, and have difficulties adhering to medication. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.